CVS Health Stock Price, News & Analysis (NYSE:CVS)

$72.85 -0.23 (-0.31 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$73.08
Today's Range$72.17 - $73.19
52-Week Range$66.45 - $84.72
Volume8.23 million shs
Average Volume6.96 million shs
Market Capitalization$74.04 billion
P/E Ratio12.8
Dividend Yield2.74%
Beta0.89

About CVS Health (NYSE:CVS)

CVS Health logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Retailers
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:CVS
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio0.67%
Current Ratio1.05%
Quick Ratio0.55%

Price-To-Earnings

Trailing P/E Ratio12.8
Forward P/E Ratio12.35
P/E Growth1.37

Sales & Book Value

Annual Sales$177.53 billion
Price / Sales0.42
Cash Flow$8.20 per share
Price / Cash8.88
Book Value$34.54 per share
Price / Book2.11

Profitability

Trailing EPS$4.84
Net Income$5.32 billion
Net Margins2.77%
Return on Equity16.96%
Return on Assets6.36%

Miscellaneous

Employees250,000
Outstanding Shares1,012,990,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Tuesday, September 19th. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share on Friday, November 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.75%. The ex-dividend date of this dividend is Monday, October 23rd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Monday, November, 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.49 by $0.01. The pharmacy operator had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm's revenue was up 3.5% on a year-over-year basis. During the same period last year, the company posted $1.64 EPS. View CVS Health's Earnings History.

When will CVS Health make its next earnings announcement?

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February, 8th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its fourth quarter earnings guidance on Monday, November, 6th. The company provided earnings per share guidance of $1.88-1.92 for the period, compared to the Thomson Reuters consensus estimate of $1.91.

Where is CVS Health's stock going? Where will CVS Health's stock price be in 2017?

20 Wall Street analysts have issued 12-month target prices for CVS Health's shares. Their predictions range from $73.00 to $106.67. On average, they expect CVS Health's stock price to reach $86.10 in the next year. View Analyst Ratings for CVS Health.

What are Wall Street analysts saying about CVS Health stock?

Here are some recent quotes from research analysts about CVS Health stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in October. As of October 31st, there was short interest totalling 24,837,344 shares, an increase of 16.1% from the October 13th total of 21,400,669 shares. Based on an average daily volume of 10,995,147 shares, the short-interest ratio is presently 2.3 days. Currently, 2.5% of the company's shares are short sold.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board (Age 63)
  • Larry J. Merlo, President, Chief Executive Officer, Director (Age 61)
  • David M. Denton, Chief Financial Officer, Executive Vice President (Age 52)
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President (Age 61)
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President (Age 60)
  • Stephen J. Gold, Executive Vice President, Chief Information Officer (Age 57)
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer (Age 53)
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy (Age 52)
  • J. David Joyner, Executive Vice President (Age 52)

Who owns CVS Health stock?

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Barrow Hanley Mewhinney & Strauss LLC (1.60%), Nordea Investment Management AB (1.39%), Dimensional Fund Advisors LP (1.07%), Bank of New York Mellon Corp (1.04%), Macquarie Group Ltd. (0.87%) and Veritas Asset Management LLP (0.85%). Company insiders that own CVS Health stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Who sold CVS Health stock? Who is selling CVS Health stock?

CVS Health's stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Macquarie Group Ltd., Barrow Hanley Mewhinney & Strauss LLC, Canada Pension Plan Investment Board, Amundi Pioneer Asset Management Inc., Retirement Systems of Alabama, CI Investments Inc. and Swedbank. Company insiders that have sold CVS Health company stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Who bought CVS Health stock? Who is buying CVS Health stock?

CVS Health's stock was acquired by a variety of institutional investors in the last quarter, including Truepoint Inc., Ameriprise Financial Inc., Stifel Financial Corp, Boston Partners, American Century Companies Inc., Bank of New York Mellon Corp, Legal & General Group Plc and Dimensional Fund Advisors LP. View Insider Buying and Selling for CVS Health.

How do I buy CVS Health stock?

Shares of CVS Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS Health stock can currently be purchased for approximately $72.85.

How big of a company is CVS Health?

CVS Health has a market capitalization of $74.04 billion and generates $177.53 billion in revenue each year. The pharmacy operator earns $5.32 billion in net income (profit) each year or $4.84 on an earnings per share basis. CVS Health employs 250,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  880 (Vote Outperform)
Underperform Votes:  392 (Vote Underperform)
Total Votes:  1,272
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CVS Health (NYSE:CVS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.652.652.67
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $89.44$88.99$94.75$97.13
Price Target Upside: 24.76% upside28.93% upside18.85% upside21.90% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2017Raymond James FinancialReiterated RatingBuyLowView Rating Details
12/5/2017Deutsche BankReiterated RatingBuy -> HoldMediumView Rating Details
12/4/2017Royal Bank of CanadaSet Price TargetBuy$95.00LowView Rating Details
12/4/2017Robert W. BairdSet Price TargetHold$77.00MediumView Rating Details
12/4/2017Jefferies GroupSet Price TargetHold$76.00MediumView Rating Details
12/4/2017Loop CapitalSet Price TargetHold$73.00MediumView Rating Details
12/4/2017CitigroupSet Price TargetHold$76.00MediumView Rating Details
12/4/2017Leerink SwannSet Price TargetBuy$85.00HighView Rating Details
12/4/2017Needham & Company LLCBoost Price TargetBuy$79.00 -> $85.00HighView Rating Details
10/29/2017CowenSet Price TargetBuy$86.00N/AView Rating Details
10/24/2017MizuhoSet Price TargetBuy$90.00N/AView Rating Details
10/12/2017SunTrust BanksSet Price TargetBuy$85.00N/AView Rating Details
10/9/2017OppenheimerReiterated RatingBuy$95.00N/AView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
2/28/2017Bank of AmericaReiterated RatingBuy$106.67N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016BarclaysReiterated RatingBuy$85.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
2/10/2016Goldman Sachs GroupBoost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018N/AView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.17 billion$46.18 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

CVS Health (NYSE:CVS) Earnings Estimates

2017 EPS Consensus Estimate: $5.90
2018 EPS Consensus Estimate: $6.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20175$1.47$1.64$1.51
Q4 20175$1.88$1.90$1.89
Q1 20185$1.12$1.49$1.28
Q2 20185$1.42$1.62$1.47
Q3 20184$1.63$1.82$1.70
Q4 20184$1.97$2.07$2.01
Q1 20192$1.24$1.34$1.29
Q2 20192$1.54$1.59$1.57
(Data provided by Zacks Investment Research)

Dividends

CVS Health (NYSE:CVS) Dividend Information

Most Recent Dividend:11/3/2017
Annual Dividend:$2.00
Dividend Yield:2.75%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:41.32% (Trailing 12 Months of Earnings)
33.90% (Based on This Year's Estimates)
31.80% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.431.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.431.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.431.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.431.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.281.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.281.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.281.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.281.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.231.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.231.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.231.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.231.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 82.24%
Insider Trades by Quarter for CVS Health (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.99View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.20View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.87View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.00View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.00View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CVS Health (NYSE CVS) News Headlines

Source:
DateHeadline
Hospitals Are Merging to Face Off With InsurersHospitals Are Merging to Face Off With Insurers
finance.yahoo.com - December 11 at 5:05 PM
CVS Health Corp. breached its 50 day moving average in a Bullish Manner : CVS-US : December 11, 2017CVS Health Corp. breached its 50 day moving average in a Bullish Manner : CVS-US : December 11, 2017
finance.yahoo.com - December 11 at 10:43 AM
Hospitals Merge To Protect Turf As CVS And Optum Move InHospitals Merge To Protect Turf As CVS And Optum Move In
finance.yahoo.com - December 10 at 9:54 AM
See what the IHS Markit Score report has to say about CVS Health Corp.See what the IHS Markit Score report has to say about CVS Health Corp.
finance.yahoo.com - December 9 at 10:00 AM
The Week That Was: Bitcoin soars, government shutdown ave...The Week That Was: Bitcoin soars, government shutdown ave...
finance.yahoo.com - December 8 at 4:48 PM
CVS Health Corp Buys Aetna. So Who Is Going To Buy Rite Aid?CVS Health Corp Buys Aetna. So Who Is Going To Buy Rite Aid?
investorplace.com - December 8 at 12:46 PM
CVS, Aetna boast of synergies, but thats just corporate speakCVS, Aetna boast of 'synergies,' but that's just corporate speak
www.msn.com - December 7 at 5:13 PM
This year's plans for job cuts at lowest level since 1997, Challenger report saysThis year's plans for job cuts at lowest level since 1997, Challenger report says
finance.yahoo.com - December 7 at 5:13 PM
ETFs with exposure to CVS Health Corp. : December 7, 2017ETFs with exposure to CVS Health Corp. : December 7, 2017
finance.yahoo.com - December 7 at 5:13 PM
Trump Tax Cuts Will Fuel Economic Growth At The Right TimeTrump Tax Cuts Will Fuel Economic Growth At The Right Time
finance.yahoo.com - December 7 at 5:13 PM
CVS Health Corp (CVS) Given Average Rating of "Buy" by AnalystsCVS Health Corp (CVS) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 7 at 2:38 PM
Wall Street Is Wary of an Untested Strategy in CVS-Aetna ... - BloombergWall Street Is Wary of an Untested Strategy in CVS-Aetna ... - Bloomberg
www.bloomberg.com - December 6 at 4:56 PM
CVS Boss Larry Merlos Path From Corner Pharmacy to C-Suite - Wall Street JournalCVS Boss Larry Merlo's Path From Corner Pharmacy to C-Suite - Wall Street Journal
www.wsj.com - December 6 at 4:56 PM
The CVS-Aetna Merger: Under The Shadow Of Amazon? - Seeking AlphaThe CVS-Aetna Merger: Under The Shadow Of Amazon? - Seeking Alpha
seekingalpha.com - December 6 at 4:56 PM
CVS Health Corp. Dividend Stock Analysis - Seeking AlphaCVS Health Corp. Dividend Stock Analysis - Seeking Alpha
seekingalpha.com - December 6 at 4:56 PM
CVS Healthcare Is No Longer A Dividend Growth Company - Seeking AlphaCVS Healthcare Is No Longer A Dividend Growth Company - Seeking Alpha
seekingalpha.com - December 6 at 4:56 PM
CVS Wants Aetna; Does Anyone Want Blue Apron?CVS Wants Aetna; Does Anyone Want Blue Apron?
finance.yahoo.com - December 6 at 4:56 PM
MARKET FOOLERY // 12-04-2017MARKET FOOLERY // 12-04-2017
finance.yahoo.com - December 6 at 4:56 PM
Aetna CEO reportedly could get $500M if CVS deal closesAetna CEO reportedly could get $500M if CVS deal closes
finance.yahoo.com - December 6 at 4:56 PM
CVS Health Corp to Post FY2018 Earnings of $6.17 Per Share, Oppenheimer Forecasts (CVS)CVS Health Corp to Post FY2018 Earnings of $6.17 Per Share, Oppenheimer Forecasts (CVS)
www.americanbankingnews.com - December 6 at 3:36 PM
CVS Health Corp. (CVS) Slid After Aetna AcquisitionCVS Health Corp. (CVS) Slid After Aetna Acquisition
www.rttnews.com - December 6 at 10:09 AM
CVS-Aetna Deal: What's Hot, What's NotCVS-Aetna Deal: What's Hot, What's Not
finance.yahoo.com - December 6 at 10:09 AM
Rep. Pallone calls for hearing on CVS-Aetna dealRep. Pallone calls for hearing on CVS-Aetna deal
finance.yahoo.com - December 6 at 10:09 AM
Wired News – Drugstore Chain CVS Health Acquires Health Insurance Company AetnaWired News – Drugstore Chain CVS Health Acquires Health Insurance Company Aetna
finance.yahoo.com - December 6 at 10:09 AM
CVS’s Aetna Takeover Comes With a $2.1 Billion Termination FeeCVS’s Aetna Takeover Comes With a $2.1 Billion Termination Fee
finance.yahoo.com - December 6 at 10:09 AM
CVS Pharmacy Launches Free, Same-Day Prescription Delivery in ManhattanCVS Pharmacy Launches Free, Same-Day Prescription Delivery in Manhattan
finance.yahoo.com - December 6 at 10:09 AM
Transforming health care through value-based partnerships...Transforming health care through value-based partnerships...
finance.yahoo.com - December 6 at 10:09 AM
Analysts weigh pros and cons of $69B CVS merger with AetnaAnalysts weigh pros and cons of $69B CVS merger with Aetna
www.bizjournals.com - December 5 at 4:50 PM
Eight out of 10 Americans are within 10 miles of a CVSEight out of 10 Americans are within 10 miles of a CVS
finance.yahoo.com - December 5 at 4:50 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates the Acquisition of Aetna Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates the Acquisition of Aetna Inc.
finance.yahoo.com - December 5 at 4:50 PM
CVS Health (CVS) Receives Buy Rating from Raymond James FinancialCVS Health (CVS) Receives Buy Rating from Raymond James Financial
www.americanbankingnews.com - December 5 at 1:30 PM
CVS likely wants FTC antitrust review, not Justice Dept, of Aetna dealCVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal
www.cnbc.com - December 5 at 10:42 AM
Aetna’s Outgoing CEO Set to Reap About $500 Million if CVS Deal ClosesAetna’s Outgoing CEO Set to Reap About $500 Million if CVS Deal Closes
www.wsj.com - December 5 at 10:42 AM
Coventry Health Care of Missouri, Inc. -- Moodys affirms Aetnas senior notes Baa2 after announced acquisition by CVS; outlook stableCoventry Health Care of Missouri, Inc. -- Moody's affirms Aetna's senior notes Baa2 after announced acquisition by CVS; outlook stable
finance.yahoo.com - December 5 at 10:42 AM
[$$] CVS-Aetna Is More Tortoise Than Hare[$$] CVS-Aetna Is More Tortoise Than Hare
finance.yahoo.com - December 5 at 10:42 AM
Dow Notches Another Record; CVS Diversifies With Aetna Purchase -- ICYMIDow Notches Another Record; CVS Diversifies With Aetna Purchase -- ICYMI
finance.yahoo.com - December 5 at 10:42 AM
Former Aetna CEO on how the CVS-Aetna deal could reshape ...Former Aetna CEO on how the CVS-Aetna deal could reshape ...
finance.yahoo.com - December 5 at 10:42 AM
This Isnt a Rally: Cramers Mad Money Recap (Monday 12/4/17)This Isn't a Rally: Cramer's 'Mad Money' Recap (Monday 12/4/17)
finance.yahoo.com - December 5 at 10:42 AM
The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad GeneticsThe Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics
finance.yahoo.com - December 5 at 10:42 AM
The CVS-Aetna Merger Is A Mortal Threat To U.S. HospitalsThe CVS-Aetna Merger Is A Mortal Threat To U.S. Hospitals
finance.yahoo.com - December 5 at 10:42 AM
CVS likely wants FTC antitrust review, not Justice Department, of Aetna dealCVS likely wants FTC antitrust review, not Justice Department, of Aetna deal
finance.yahoo.com - December 5 at 10:42 AM
Wal-Mart May Buy Humana to Combat CVS-AetnaWal-Mart May Buy Humana to Combat CVS-Aetna
finance.yahoo.com - December 5 at 10:42 AM
Wall Street Is Wary of an Untested Strategy in CVS-Aetna MegamergerWall Street Is Wary of an Untested Strategy in CVS-Aetna Megamerger
finance.yahoo.com - December 5 at 10:42 AM
CVS Health (CVS) Rating Reiterated by Deutsche BankCVS Health (CVS) Rating Reiterated by Deutsche Bank
www.americanbankingnews.com - December 5 at 8:58 AM
Deutsche Bank Initiates Coverage on CVS Health (CVS)Deutsche Bank Initiates Coverage on CVS Health (CVS)
www.americanbankingnews.com - December 4 at 11:10 PM
CVS Health (CVS) Given a $85.00 Price Target at Leerink SwannCVS Health (CVS) Given a $85.00 Price Target at Leerink Swann
www.americanbankingnews.com - December 4 at 7:32 PM
Royal Bank Of Canada Reiterates "$95.00" Price Target for CVS Health (CVS)Royal Bank Of Canada Reiterates "$95.00" Price Target for CVS Health (CVS)
www.americanbankingnews.com - December 4 at 6:38 PM
How the CVS Aetna Deal Will Change How You Get Health CareHow the CVS Aetna Deal Will Change How You Get Health Care
fortune.com - December 4 at 4:53 PM
CVS and Aetna say their huge merger will be great for consumers. Heres why you should be skepticalCVS and Aetna say their huge merger will be great for consumers. Here's why you should be skeptical
www.latimes.com - December 4 at 4:53 PM
The CVS-Aetna Gamble: a Health-Care Giant Not Built Around DoctorsThe CVS-Aetna Gamble: a Health-Care Giant Not Built Around Doctors
www.wsj.com - December 4 at 4:53 PM

SEC Filings

CVS Health (NYSE:CVS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CVS Health (NYSE CVS) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.